Sporotrichosis surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{AJL}}
{{CMG}}; {{AE}} {{AJL}}
==Overview==
==Overview==
Surgery is not the first­ line treatment option for patients with cutaneous sporotrichosis. Surgical therapy is usually reserved for patients with either osteoarticular sporotrichosis or pulmonary sporotrichosis.  
[[Surgery]] is not the first­ line treatment option for patients with cutaneous sporotrichosis. [[Surgery|Surgical]] therapy is usually reserved for patients with either osteoarticular sporotrichosis or pulmonary sporotrichosis.  


==Surgery==
==Surgery==
*Surgical therapy may be necessary in the management of osteoarticular sporotrichosis, a form of sporotrichosis that impacts bones and joints.
*[[Surgery|Surgical]] therapy may be necessary in the management of osteoarticular sporotrichosis, a form of sporotrichosis that impacts bones and joints.
:*Draining impacted joints can help minimize permanent damage.  
**[[Drain (surgery)|Draining]] impacted joints can help minimize permanent damage.  
:*Debridement of impacted bone may help increase the effectiveness of pharmaceutical treatments.<ref name="pmid17438048">{{cite journal| author=Alvarado-Ramírez E, Torres-Rodríguez JM| title=In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods. | journal=Antimicrob Agents Chemother | year= 2007 | volume= 51 | issue= 7 | pages= 2420-3 | pmid=17438048 | doi=10.1128/AAC.01176-06 | pmc=PMC1913275 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17438048  }} </ref>
**[[Debridement]] of impacted bone may help increase the effectiveness of pharmaceutical treatments.<ref name="pmid17438048">{{cite journal| author=Alvarado-Ramírez E, Torres-Rodríguez JM| title=In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods. | journal=Antimicrob Agents Chemother | year= 2007 | volume= 51 | issue= 7 | pages= 2420-3 | pmid=17438048 | doi=10.1128/AAC.01176-06 | pmc=PMC1913275 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17438048  }} </ref>
*In cases of cavitatory nodules in the lungs, surgery may be necessary.
 
*In cases of cavitary [[nodules]] in the [[lungs]], [[surgery]] may be necessary.


==References==
==References==

Revision as of 16:26, 28 January 2016

Sporotrichosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sporotrichosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Treatment

Medical Therapy

Surgery

Prevention

Case Studies

Case #1

Sporotrichosis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sporotrichosis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sporotrichosis surgery

CDC on Sporotrichosis surgery

Sporotrichosis surgery in the news

Blogs on Sporotrichosis surgery

Directions to Hospitals Treating Sporotrichosis

Risk calculators and risk factors for Sporotrichosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alison Leibowitz [2]

Overview

Surgery is not the first­ line treatment option for patients with cutaneous sporotrichosis. Surgical therapy is usually reserved for patients with either osteoarticular sporotrichosis or pulmonary sporotrichosis.

Surgery

  • Surgical therapy may be necessary in the management of osteoarticular sporotrichosis, a form of sporotrichosis that impacts bones and joints.
    • Draining impacted joints can help minimize permanent damage.
    • Debridement of impacted bone may help increase the effectiveness of pharmaceutical treatments.[1]

References

  1. Alvarado-Ramírez E, Torres-Rodríguez JM (2007). "In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods". Antimicrob Agents Chemother. 51 (7): 2420–3. doi:10.1128/AAC.01176-06. PMC 1913275. PMID 17438048.